The pharmacologic closure of the patent ductus arteriosus.
about
Oral medications regarding their safety and efficacy in the management of patent ductus arteriosusThe molecular genetics and cellular mechanisms underlying pulmonary arterial hypertensionFailure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants.Multiple courses of indomethacin and neonatal outcomes in premature infants.The Association between Patent Ductus Arteriosus and Perinatal Infection in A Group of Low Birth Weight Preterm Infants.Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health.Patent ductus arteriosus: an overviewPatent ductus arteriosus in preterm infants: do we have the right answers?Regulation of the pulmonary circulation in the fetus and newborn.Paracetamol to induce ductus arteriosus closure: is it valid?Diagnosis and management of fetal ductus arteriosus constriction-closure.The impact of a dedicated patent ductus arteriosus ligation team on neonatal health-care outcomes.Milrinone use for hemodynamic instability in patent ductus arteriosus ligation.Renal Side Effects of Non-Steroidal Anti-Inflammatory Drugs in NeonatesAn optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study.Paracetamol in Patent Ductus Arteriosus Treatment: Efficacious and Safe?Ibuprofen lysine (NeoProfen) for the treatment of patent ductus arteriosus.The impact of ibuprofen or indomethacin on renal drug clearance in neonates.Intraperitoneal medetomidine: a novel analgesic strategy for postoperative pain management in pregnant sheep.Paracetamol therapy for patent ductus arteriosus in premature infants: a chance before surgical ligation.Indomethacin-associated neutropenia with subsequent Gram-negative sepsis in a preterm infant. Cause or coincidence?Cardiac sonography by the neonatologist: clinical usefulness and educational perspective.Quantitative assessment of the degree of ductal steal using celiac artery blood flow to left ventricular output ratio in preterm infants.Efficacy and safety of rectal ibuprofen for patent ductus arteriosus closure in very low birth weight preterm infants.Oral Paracetamol for Patent Ductus Arteriosus Rescue Closure.Plasma and cerebrospinal fluid concentrations of indomethacin in children after intravenous administration.A Descriptive Study on the Neonatal Morbidity Profile of Autism Spectrum Disorders, Including a Comparison with Other Neurodevelopmental Disorders.Oral paracetamol versus oral ibuprofen for closure of haemodynamically significant patent ductus arteriosus in preterm neonates (<32 weeks): a blinded, randomised, active-controlled, non-inferiority trialInterpretation of Cerebral Oxygenation Changes in the Preterm InfantEvaluation of cerebral electrical activity and cardiac output after patent ductus arteriosus ligation in preterm infants
P2860
Q26766965-FA3FC180-A720-42C7-8A88-C4523DBAA29AQ26992278-D84F4DBB-8A77-4F6D-B7D9-58FFE21A6C0CQ34143373-3510A3AA-F8C5-468A-9C12-332A8334CE22Q34846689-EF28C63A-AB85-402C-9DFE-47462355CC72Q35177310-F41E5541-9895-40FD-BCEF-4D4365E4AE31Q36244610-546D6432-BF4E-4380-8B05-1E246E0F5B32Q36290879-395139F4-7A38-409E-A064-FF0199644DF4Q37451050-C1E81AB1-C3D6-4AC4-BA7F-38CACBAF3C16Q37801516-B4F5DF86-7876-4FFE-AF4C-D05D274C2589Q38100781-DA216498-A0A5-4878-A7E3-54644DC35585Q38372654-57AEA72D-6DFB-4A9C-9787-717627E98165Q38696249-ECA19031-5867-4A8C-B13A-587E0BB999AFQ38806805-1B0E0DA7-D338-4479-8938-9587FFE7E302Q38974176-35D4D7ED-C357-4978-8B3E-74BCB89190B9Q39316964-881742DD-B1A6-4B15-BB48-B5A098AD8CE5Q41371050-C95754FC-C567-4E02-8647-45B610B7F28DQ43011724-3FFA5D3C-D903-474E-99F4-846B9C06045FQ43287324-C8E2B462-270A-4305-A3D5-4EA5C33B70E6Q43410274-3567E1F6-0BE3-4A28-851A-07B86A4759E5Q43676939-5A8873AB-FE18-49AC-ACBC-828128D807F3Q46024330-567B615D-02BC-42A6-B0CD-88CCB70BC174Q46755897-3C954AB3-491F-4A29-89F6-3E9679424735Q46908084-1387D521-F4C9-4F98-974F-B0A6AA470DD7Q47246033-7918E3FD-4D53-4B5E-B528-7E0462FFADB3Q47771724-4B17E9B6-3195-4B0C-8585-5B4CC4320DAFQ48633680-D8D1CA56-E15B-4DE6-BCBC-62F7806D1ADAQ50313389-D6CB6707-E445-4DF8-BCBA-D4EBDE229D1CQ56763293-2F14BFF5-22CB-4E98-9686-73FB92481D0CQ57260305-5BA0D509-11A3-4795-B479-449E400D4E9EQ59161621-57E6CB07-D0D0-4503-90B9-693B8EC774EC
P2860
The pharmacologic closure of the patent ductus arteriosus.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The pharmacologic closure of the patent ductus arteriosus.
@ast
The pharmacologic closure of the patent ductus arteriosus.
@en
type
label
The pharmacologic closure of the patent ductus arteriosus.
@ast
The pharmacologic closure of the patent ductus arteriosus.
@en
prefLabel
The pharmacologic closure of the patent ductus arteriosus.
@ast
The pharmacologic closure of the patent ductus arteriosus.
@en
P1476
The pharmacologic closure of the patent ductus arteriosus.
@en
P2093
Bart Van Overmeire
Sylvain Chemtob
P304
P356
10.1016/J.SINY.2004.10.003
P577
2004-12-15T00:00:00Z